Explore asthma, COPD, palpitations, and sleep apnea through the lens of autonomic nervous system function and heart rate variability — a 15-minute assessment that complements pulmonary function testing.

Autonomic imbalance plays a role in airway reactivity. HRV metrics provide objective markers of asthma-related autonomic dysfunction.
Patients with COPD show altered autonomic function. ANS testing quantifies sympathetic/parasympathetic balance to guide management.
Obstructive sleep apnea disrupts autonomic regulation. ANS testing identifies cardiovascular risk markers associated with sleep-disordered breathing.
Autonomic testing helps differentiate benign palpitations from those with underlying autonomic dysfunction.
US MedResources equips pulmonology practices nationwide with FDA-cleared autonomic and vascular diagnostic technology. From New York to Los Angeles, Chicago to Miami, practices rely on VitalScan ANS+ for early detection of pulmonology conditions — with CPT-billable testing that fits into a single patient visit.
Request an ROI & Quote95921–95924Autonomic nervous system function testing93922–93971Vascular studies for cardiopulmonary assessmentEstimated monthly revenue
3 tests/day × ~$190 avg = $11,400/month
Based on 3 tests per day, 20 working days per month. Actual reimbursement varies by payer and region.
Get a personalized growth plan with clinical workflow, CPT billing guidance, and financing options — including Section 179 and grant pathways.